Tr1x, Inc.
Clinical trials sponsored by Tr1x, Inc., explained in plain language.
-
New cell therapy trial aims to slow progressive MS
Disease control Recruiting nowThis early-stage trial tests TRX319, a cell therapy, in 39 adults with primary or secondary progressive multiple sclerosis (MS). The main goals are to check safety and find the best dose, with or without a pre-treatment called Bendamustine. Participants will receive up to three i…
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC
-
New cell therapy TRX103 offers hope for tough Crohn's cases
Disease control Recruiting nowThis study tests a new treatment called TRX103 for people with moderate to severe Crohn's disease that hasn't improved with other treatments. The goal is to see if TRX103 is safe and can help control the disease. About 39 adults aged 18 to 65 will receive different doses of TRX10…
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC